Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBiogipuzkoa Health Research Institute

About this trial

People living with HIV now have a life expectancy similar to that of the general population, thanks to major advances in antiretroviral treatment. As they live longer, many of them experience multiple health conditions at the same time and take several medications, often more than people without HIV. In our region, 6,273 people are currently receiving antiretroviral therapy. However, the new care pathway designed for patients with multiple chronic conditions in the Basque Country's public health system does not include people with HIV. At the same time, we lack local data on how common multimorbidity, polypharmacy, and potentially inappropriate prescribing are among this group. These gaps motivated our study. Our goal is to estimate how frequent these issues are among all people with HIV who receive care in the infectious disease departments of the hospitals in Araba, Basurto, Galdakao, Cruces, and Donostia, and to compare them with a similar group of people without HIV. To do this, we designed a cross-sectional study including the 6,273 people with HIV and a control group from the general population, selected to match them by age, sex, and health centre. By analysing data from electronic health records, we aim to determine whether people with HIV have higher rates of multimorbidity, polypharmacy, and inappropriate prescribing than the general population. The findings from both groups will help us update the care pathway and improve coordinated care for HIV-positive patients with multiple health conditions.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

People with HIV aged 18 or over

Being monitored by the infectious diseases departments of the Araba, Cruces, Basurto and Donostia University Hospitals and the Galdakao-Usansolo Hospital, all part of Osakidetza.

Disqualifiers

None

Trial population

People with HIV aged 18 or over who are being monitored by the infectious diseases departments of the Araba, Cruces, Basurto and Donostia University Hospitals and the Galdakao-Usansolo Hospital, all part of Osakidetza. Five HIV-negative controls will be selected for each person with HIV. Stratified random sampling will be carried out by age, sex and referral hospital, according to the composition of the HIV population.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention

Treatment groups

12,546 Participants
are divided into 2 treatment groups
Group A: People with HIV1 intervention
Group B: General population1 intervention

Trial outcomes

Primary outcomes

1

Prevalence of multimorbidity in people with HIV in the Basque Country

Proportion of people with HIV aged ≥18 years who have ≥2 chronic diseases recorded in their electronic health records. Automated extraction of active diagnoses coded in the electronic health records.

Time frame
Enrollment
2

Prevalence of multimorbidity in the general population in the Basque Country

Proportion of people aged ≥18 years who have ≥2 chronic diseases recorded in their electronic health record. Automated extraction of active diagnoses coded in the electronic health records.

Time frame
Enrollment
3

Prevalence of polypharmacy in people with HIV in the Basque Country

Proportion of people with HIV aged ≥18 years who have ≥5 prescribed medications and ≥10 medications (excessive polypharmacy) as chronic or on demand treatments, excluding antiretroviral therapy. Adherence according to the dispensing records.

Time frame
Enrollment
4

Prevalence of polypharmacy in the general population in the Basque Country

Proportion of people aged ≥18 years who have ≥5 prescribed medications and ≥10 medications (excessive polypharmacy) as chronic or on demand treatments, excluding antiretroviral therapy. Adherence according to the dispensing records.

Time frame
Enrollment

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: